In one paragraphArticle in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors at 3 institutions in 2 countries.
Patricia GrabherDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.ORCID 0009-0009-5121-4686 Paul KapitzaDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.ORCID 0000-0003-1464-8767 Nikolas HörmannDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.
Amelie ScherflerDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.
Martin HermannDepartment of Anesthesiology & Critical Care Medicine, Medical University Innsbruck, Anichstraße 35, Innsbruck A-6020, Austria.
Michael ZwergerDepartment of Pharmacognosy, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.
Hristo P VarbanovDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.ORCID 0000-0003-4450-7332 Brigitte KircherDepartment of Internal Medicine V, Haematology & Oncology, Immunobiology and Stem Cell Laboratory, Medical University Innsbruck, Anichstraße 35, Innsbruck A-6020, Austria.ORCID 0000-0003-1624-2664 Daniel BaeckerDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2 + 4, Berlin D-14195, Germany.ORCID 0000-0002-1963-9838 Ronald GustDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria.ORCID 0000-0002-0427-4012 Universität Innsbruck · ATInnsbruck Medical University · ATFreie Universität Berlin · DE
Funding
Austrian Science Fund FWF P 31166
6 · The paper itselfAbstract
Indexed as
Antineoplastic AgentsEstrogen Receptor alphaEstrogen Receptor betaHumansLigandsMCF-7 CellsReceptor Protein-Tyrosine KinasesAntineoplastic AgentsEstrogen Receptor alphaEstrogen Receptor betaLigandsReceptor Protein-Tyrosine Kinases
Identifiers
PMID38478882
PMCPMC10983001
OpenAlexW4392744502
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390